Gene · 5933
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and epigenetic dependencies in colorectal cancer development. | Gastroenterol Rep (Oxf) | 2022 | 35975243 | PubTator, text mining | PubMed |
| circRAB3IP modulates cell proliferation by reorganizing gene expression and mRNA processing in a paracrine manner. | RNA | 2022 | 35973723 | PubTator, text mining | PubMed |
| HPV and head and neck cancers: Towards early diagnosis and prevention. | Tumour Virus Res | 2022 | 35973657 | PubTator, text mining | PubMed |
| Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers. | Clin Cancer Res | 2022 | 35972731 | PubTator, text mining | PubMed |
| In silico gene expression and pathway analysis of DEK in the human brain across the lifespan. | Eur J Neurosci | 2022 | 35972263 | PubTator, text mining | PubMed |
| GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2022 | 35960100 | PubTator, text mining | PubMed |
| Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma. | Cancers (Basel) | 2022 | 35954335 | PubTator, text mining | PubMed |
| Conformational buffering underlies functional selection in intrinsically disordered protein regions. | Nat Struct Mol Biol | 2022 | 35948766 | PubTator, text mining | PubMed |
| Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus. | Nat Commun | 2022 | 35948546 | PubTator, text mining | PubMed |
| Cellular senescence: the good, the bad and the unknown. | Nat Rev Nephrol | 2022 | 35922662 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence. | Stem Cells Int | 2022 | 35910534 | PubTator, text mining | PubMed |
| A Journey to the Core of the Plant Cell Cycle. | Int J Mol Sci | 2022 | 35897730 | PubTator, text mining | PubMed |
| New Perspectives in Therapeutic Vaccines for HPV: A Critical Review. | Medicina (Kaunas) | 2022 | 35888579 | PubTator, text mining | PubMed |
| Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line. | Int J Mol Sci | 2022 | 35886999 | PubTator, text mining | PubMed |
| The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth. | Cancers (Basel) | 2022 | 35884550 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Antimicrobial Peptides as Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes. | Front Cell Dev Biol | 2022 | 35874827 | PubTator, text mining | PubMed |
RNA Sequencing Reveals the Expression Profiles of circRNAs and Indicates Hsa_circ_0070562 as a Pro-osteogenic Factor in Bone Marrow-Derived Mesenchymal Stem Cells of Patients With Ankylosing Spondylitis. | Front Genet | 2022 | 35873481 | PubTator, text mining | PubMed |
| Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature. | Neoplasia | 2022 | 35872559 | PubTator, text mining | PubMed |
| Emerging Role of Non-Coding RNAs in Senescence. | Front Cell Dev Biol | 2022 | 35865636 | PubTator, text mining | PubMed |
| E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry. | Int J Biol Sci | 2022 | 35844795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5933/papers?page=13